VC and Investment
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Today's issue
Refine Search
Biotechnology
UK drug delivery company SkyePharma said it sees its cash balance being ahead of expectations at the end of the financial year. 27 November 2015
Pharmaceutical
Swiss biopharmaceutical company ObsEva said it has raised $60 million via a Series B equity placing with some big new investors. 24 November 2015
Pharmaceutical
Spanish pharma company Zeltia has restructured and is now trading as PharmaMar. 16 November 2015
Pharmaceutical
Michael Pearson, chief executive of Valeant Pharmaceuticals, warned that the company’s decision to cut ties with its pharmacy partner Philidor would have a negative impact on its dermatology business. 11 November 2015
Biotechnology
Biotech firm Zealand Pharma announced a restructuring plan as it swung to a loss in third-quarter loss. 5 November 2015
Pharmaceutical
ValiRx on Thursday said it has set up its US operations in Cambridge, Boston, Massachusetts and has also appointed industry specific advisors in the US. 5 November 2015
Pharmaceutical
Better-than-expected revenues from cancer therapy Opdivo (nivolumab) were a major driver behind Bristol-Myers Squibb beating third quarter profit estimates. 27 October 2015
Pharmaceutical
Reassurance on the future of the UK’s Patent Box Scheme is positive news for UK companies, according to leading intellectual property firm, Withers & Rogers. 26 October 2015
Biotechnology
Danish biotech company Genmab said it is set to receive $3 million in milestone payment from Janssen Biotech, a unit of US health care giant Johnson & Johnson, following a pre-clinical advancement for its DuoBody technology platform. 26 October 2015
Pharmaceutical
India’s Piramal Enterprises said the injectables-market review from its pharma solutions unit indicates the near-term growth prospects are highest across generics, small molecule injectables, and in contract services. 14 October 2015
Pharmaceutical
Zealand Pharma on Friday said German drugmaker Boehringer Ingelheim will pay 3 million euros ($3.4 million) in milestones to the company following the selection of a new peptide therapeutic for advanced preclinical development. 9 October 2015
Pharmaceutical
CSL Limited on Friday said it has closed a new 400 million Swiss Franc ($415.8 million) and $100 million via a private placement in the USA. 9 October 2015
Biotechnology
Concert Pharmaceuticals on Thursday said it has received $8 million in milestone payments from US biotech company Celgene Corp following the completion of early stage trial of the drug candidate to treat for inflammatory diseases and cancer. 8 October 2015
Pharmaceutical
TauRx Pharmaceuticals on Thursday said it has completed the final tranche of a $135 million equity financing launched in March to aid late-stage trials for its drugs to treat Alzheimer's and frontotemporal dementia. 8 October 2015
Pharmaceutical
Specialty pharma company Pharmalink on Thursday said it is planning an initial public offering on Nasdaq Stockholm in 2016 to fund the development of its lead drug candidate to treat a kidney disease and that it has raised 100 million Swedish kronor ($12 million) from its investors to advance its research for its Nefecon (PL-56). 1 October 2015
Biotechnology
MetaCure, the medical technology business focussed on diabetes devices, is looking at annual revenue of $20 million following the roll-out of its flagship product, the company’s founder Professor Shlomo Ben-Haim said in an exclusive interview to The Pharma Letter. 8 September 2015
Pharmaceutical
Shield Therapeutics on Monday said it plans to raise up to £110 million ($169 million) via an initial public offering of its shares on the London Stock Exchange. 7 September 2015
Pharmaceutical
Finnish biopharma company Faron has announced its intention to raise new funds through a placing and offer for subscriptions, and to apply for trading on the AIM market of the London Stock Exchange. 7 September 2015
Generics
USA-headquartered generics manufacturer Amneal has announced the creation of Amneal Biosciences, which will be a wholly-owned subsidiary of Amneal Pharmaceuticals. 26 August 2015
Biotechnology
Google has announced it is segregating its life sciences unit into an independent company under the newly created parent group Alphabet. 24 August 2015
Biotechnology
San Francisco, USA-based biotech start-up Kivu Bioscience has announced the closing of a $92 million Series A financing round led by Novo Holdings, which as of year-end 2011123 had total assets of 149 billion euros ($161 billion). 28 October 2024
Biotechnology
Ottimo Pharma, a biotech founded by Medicxi in 2020, has emerged from stealth mode with an executive team packed with prominent industry leaders. 28 October 2024
Biotechnology
Biostar Pharmaceuticals has announced its upcoming initial public offering (IPO) on the Hong Kong Stock Exchange, aiming to raise funds to advance its growing oncology pipeline and support its global expansion efforts. 25 October 2024
Biotechnology
Belgian biotech Agomab Therapeutics today announced a $89 million (82.1 million euros) Series D financing round, with participation from new investors Sanofi and Invus 25 October 2024
Pharmaceutical
Alpha-9 Oncology, a Canadian radiopharmaceutical company, has raised $175 million in an oversubscribed series C financing round led by Lightspeed Venture Partners and Ascenta Capital. 24 October 2024
Biotechnology
US clinical-stage biotech AvenCell Therapeutics announced that it has raised $112 million in Series B financing, which was led by global life sciences investor Novo Holdings. 23 October 2024
Biotechnology
Boston, USA-based Seaport Therapeutics has announced the closing of an oversubscribed $225 million Series B financing round, adding to the $100 million it pulled in along with its launch in April. 21 October 2024
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Biotechnology
LaNova Medicines, a Shanghai-based biopharma company, has announced that it has secured 3 billion yuan ($41 million) in its series C funding round. 18 October 2024
Biotechnology
California, USA-based biotech Terray Therapeutics, yesterday announced the closing of an oversubscribed Series B funding of $120 million. 18 October 2024
Pharmaceutical
Sanofi has entered into an agreement with Orano Med, a subsidiary of the Orano Group, to advance the development of radioligand therapies for rare cancers. 17 October 2024
Pharmaceutical
Netherlands-based life sciences venture capital firm Forbion has raised more than 2 billion euros ($2.2 billion) across its two newest funds. 16 October 2024
Pharmaceutical
The American Lung Association Research Institute has announced a $22 million research investment in 2024, marking one of the largest lung health research programs in the USA. 16 October 2024
Pharmaceutical
TenNor Therapeutics, a Suzhou-based clinical-stage biotech company, has announced the initial closing of a series E financing round, raising over 300 million yuan ($41 million). 16 October 2024
Biotechnology
In Cambridge, UK, the protein specialist Nuclera has raised $75 million in a funding round led by Elevage Medical Technologies and backed by Patient Square Capital. 16 October 2024
Biotechnology
Tolerance Bio has announced the closing of its oversubscribed $17.2 million seed financing round, led by Columbus Venture Partners. 16 October 2024
Biotechnology
In Hong Kong, Akeso Biopharma has successfully raised $250 million through a share placement, marking its second major fundraising effort of 2024. 15 October 2024
Pharmaceutical
French biopharma company Inventiva has announced financing of immediately 94.1 million euros ($103 million) and up to 348 million euros, subject to satisfaction of specified conditions. 15 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Biotechnology
Boston, USA-based Upstream Bio, a biotech developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, has made an impressive start to life as a public-listed company.00000 14 October 2024
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze